Stephen L. Huhn - 13 Aug 2024 Form 4 Insider Report for Contineum Therapeutics, Inc. (CTNM)

Signature
/s/ Peter Slover, Attorney-in-Fact
Issuer symbol
CTNM
Transactions as of
13 Aug 2024
Net transactions value
+$12,928
Form type
4
Filing time
14 Aug 2024, 18:03:27 UTC
Previous filing
29 May 2024
Next filing
31 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTNM Class A Common Stock Options Exercise $12,928 +12,800 $1.01* 12,800 13 Aug 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTNM Stock Option (right to buy) Options Exercise $0 -12,800 -7.3% $0.000000 161,394 13 Aug 2024 Class A Common Stock 12,800 $1.01 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of Class A Common Stock.
F2 Options granted under the Issuer's 2012 Equity Incentive Plan. The option is fully vested.